Replies to post #5613 on Halozyme Therapeutics Inc (HALO)

[jamtomorrow2]

“Physicians are very comfortable with the IV formulation”.

Of course who’s to say that those wretched US doctors and hospitals, that put their own finances ahead of patients’ comfort and convenience, won’t play the very same sorry game when HALO’s other partners eventually launch their own SQ versions of their leading IV drugs. It appears that Roche is not prepared to take on these doctors and hospitals in fear of their other drugs being ostrasized. Someone in authority should take the lead here. Bribery and corruption is a serious crime and when you get a world leading Pharma caving in to it something needs to be done. At the present time HALO’s claim of having over $1b in annual royalties by 2027 looks ridiculously optimistic.